Director
Director at BridgeBio Pharma, Inc., filing insider transactions between 2025-06-10 and 2026-06-23. Also reports transactions at 1 other company.
| SEC ↗ |
| 2026-03-10 | BBIO | Sale | 8,671 | $72.00 | $624K | SEC ↗ |
| 2026-02-27 | BBIO | Sale | 10.9K | $67.84 | $739K | SEC ↗ |
| 2026-02-27 | BBIO | Sale | 14.6K | $67.08 | $978K | SEC ↗ |
| 2025-11-12 | BBIO | Sale | 25.5K | $66.07 | $1.7M | SEC ↗ |
| 2025-06-26 | BBIO | Sale | 1,542 | $44.01 | $68K | SEC ↗ |
| 2025-06-26 | BBIO | Sale | 876 | $44.11 | $39K | SEC ↗ |
| 2025-06-26 | BBIO | Sale | 398 | $44.13 | $18K | SEC ↗ |
| 2025-06-26 | BBIO | Sale | 1,891 | $44.03 | $83K | SEC ↗ |
| 2025-06-10 | BBIO | Sale | 4,292 | $40.00 | $172K | SEC ↗ |